The different reduction rate of prostate-specific antigen in dutasteride and finasteride.
about
Efficacy and Safety of Dutasteride in Chinese Adults with Symptomatic Benign Prostatic Hyperplasia : A Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study with an Open-Label Extension.The new insight of prostate-specific antigen reduction during finasteride therapy in aging men.Peripheral zone prostate-specific antigen density: an effective parameter for prostate cancer prediction in men receiving 5α-reductase inhibitors.Impact of treatment with statins on prostate-specific antigen and prostate volume in patients with benign prostatic hyperplasia.Prostate-Specific Antigen Kinetics Following 5α-Reductase Inhibitor Treatment May Be a Useful Indicator for Repeat Prostate Biopsy.
P2860
The different reduction rate of prostate-specific antigen in dutasteride and finasteride.
description
2010 nî lūn-bûn
@nan
2010 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
name
The different reduction rate of prostate-specific antigen in dutasteride and finasteride.
@ast
The different reduction rate of prostate-specific antigen in dutasteride and finasteride.
@en
The different reduction rate of prostate-specific antigen in dutasteride and finasteride.
@nl
type
label
The different reduction rate of prostate-specific antigen in dutasteride and finasteride.
@ast
The different reduction rate of prostate-specific antigen in dutasteride and finasteride.
@en
The different reduction rate of prostate-specific antigen in dutasteride and finasteride.
@nl
prefLabel
The different reduction rate of prostate-specific antigen in dutasteride and finasteride.
@ast
The different reduction rate of prostate-specific antigen in dutasteride and finasteride.
@en
The different reduction rate of prostate-specific antigen in dutasteride and finasteride.
@nl
P2093
P2860
P1476
The different reduction rate of prostate-specific antigen in dutasteride and finasteride.
@en
P2093
In Rae Cho
Sung Yong Cho
Yong Hyeuk Choi
P2860
P304
P356
10.4111/KJU.2010.51.10.704
P577
2010-10-21T00:00:00Z